This assessment reveals antibiotic resistance trends in salmonella serovars among clinical isolates, highlighting significant findings on colistin and trimethoprim-sulfamethoxazole.
Background: Increase in antimicrobial resistance poses a global threat for treatment of Salmonellosis. Objectives: In this study, serovar distribution, antimicrobial susceptibility, resistance genes, and clonal diversity were characterized in clinical Salmonella isolates. Methods: In this study, serovar distribution of clinical Salmonella isolates was characterized by the Kauffman-White scheme. The antimicrobial susceptibility was determined by the broth microdilution method. Resistance genes and clonal diversity were investigated by PCR and PFGE. Results: The serovars were Salmonella enterica serovar Enteritidis (n=92), Salmonella enterica serovar Typhimurium (n=14), and others (n=25). Resistance to ciprofloxacin, ceftriaxone, trimethoprim-sulfamethoxazole, azithromycin, meropenem, and colistin were 13.3%, 2.2%, 5.2%, 3.0%, 0%, 29.6%, respectively. Two ESBL-positive isolates carried TEM-type β-lactamases. Carbapenemases, mcr-1 and mcr-2 could not be detected. Colistin-resistant S. Enteritidis isolates were grouped in 4 pulsotypes [A1 (n=12), A2 (n=2), A3 (n=13) and B (n=1)]. All except one (B) were found closely related. Conclusions: A relative decrease in resistance to trimethoprim-sulfamethoxazole was detected with time. Trimethoprim-sulfamethoxazole and azithromycin can be good alternatives to the widely-used ciprofloxacin and third-generation cephalosporins. High resistance of colistin and ciprofloxacin may be due to the extensive use of antibiotics in poultry, which highlights the significance of one health concept.
No takes yet. Share an insight, caveat, or question.
Ünalan-Altıntop et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: